Best Hormone therapy Doctors Worldwide — TOP 55

Expert in personalized hormone therapy with a focus on genomic profiling – Dr. Raphael leads groundbreaking clinical trials at Sourasky Medical Center.

• Senior Lecturer with extensive experience in medical oncology
• Leader of Israel's national Genomic Medicine Initiative (PSIFAS)
• Primary investigator for multiple immunotherapy clinical trials
• European Society of Medical Oncology (ESMO) member
• Recipient of multiple teaching excellence awards from Tel-Aviv University

Dr. Pelles Sharon specializes in hormone therapy at Sourasky Medical Center (Ichilov), with notable contributions to clinical research on cancer treatments.

• Highly respected oncologist with extensive experience
• Conducted research on oncologic patients' attitudes towards clinical trials
• Provides a wide range of cancer treatments including hormone therapy
• Works at a leading medical center in Israel

Professor Ofer Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center with decades of specialized expertise.

• Over 41 years of experience experience in hormone therapy and sarcoma treatment
• Senior investigator at Weizmann Institute and Sackler Faculty of Medicine
• Member of ESMO Sarcoma group faculty
• Pioneering research collaborations in tumor immunology

Dr. Sarid specializes in hormone therapy for various cancers, combining chemotherapy, radiotherapy, and biological treatments at Sourasky Medical Center.

• Senior oncologist at Sourasky since 2009
• Trained in cancer urology at Oxford University
• Principal investigator in clinical trials for cancer therapies
• Member of ESMO and ASCO
• Lecturer at Tel Aviv University

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. Einat Shacham Shmueli is a senior medical oncologist at Sheba Medical Center. She specializes in gastrointestinal cancers, treating the colon, stomach, and pancreas. Dr. Shacham Shmueli holds dual board certifications in oncology and gastroenterology. She trained at UCSF in the United States. Her clinic at Sheba Medical Center is ranked among the top 10 hospitals worldwide.

• Authored over 25 peer-reviewed publications on tumor biology and new treatments.
• Serves as an investigator for the National Cancer Institute (NCI) programs.
• Manages metastatic disease using precision diagnostics and specialized biomarkers.
• Member of the Israel Society of Oncology and Radiotherapy.

Dr. Zamboglou leads prostate cancer research at the University of Freiburg and holds board certification in radiotherapy – specializing in hormone therapy cases.

• Board-certified in radiotherapy and radiation oncology
• Prostate cancer research group leader at University of Freiburg
• Recipient of the Herman-Holthusen Award from DEGRO
• Member of ESTRO-ACROP guideline committee for prostate cancer
• Vice Medical Director at German Medical Institute in Cyprus

Dr. Yuri Goldes is the Deputy Director of General Surgery at Sheba Medical Center. He pioneered some of Israel’s first robotic resections for stomach and pancreatic cancers. Forbes Israel named him among the nation’s best gastrointestinal surgeons. In 2019, he received the Best Doctor of the Year award from the Israeli Ministry of Health.

• Specializes in robotic and laparoscopic surgery for pancreatic, gastric, and esophageal cancers.
• Performs minimally invasive Whipple procedures, one of the most complex abdominal operations.
• Treats benign conditions including diaphragmatic hernia, achalasia, GERD, and gallbladder disease.
• Works at Sheba Medical Center, ranked among the Top 10 hospitals worldwide by Newsweek.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Fellowship-trained at Hacettepe University Cancer Institute – Dr. Solak specializes in hormone therapy for multiple cancer types.

• Deals with breast, testicular, ovarian, and lung cancers
• Residency at Istanbul Sisli Etfal Training Hospital
• Trained at The University of Texas MD Anderson Cancer Center
• Expert in gastrointestinal and head-neck cancers

Professor Yesim Yildirim specializes in cancer immunotherapy and targeted therapies, with over 80 publications in medical oncology.

• Member of European Society of Medical Oncology (ESMO)
• Expert in breast, gastrointestinal, and lung cancers
• Professor at Halic University, Istanbul
• Completed advanced training in Melanoma and Kidney Cancer Clinic in London

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Director of oncology hospitalization at Tel Aviv Medical Center – Dr. Stepfansky leads hormone therapy programs at one of Israel's top hospitals.

• 26 years of experience specializing in oncology and internal medicine
• Primary researcher in multiple clinical trials for oncology treatments
• Trained at Tel Aviv Medical Center's prestigious oncology program
• Expert in both diagnosis and management of hormonal therapies

Dr. Amir specializes in hormone therapy for breast cancer at Sourasky Medical Center, with awards from ESMO and ISCORT for his research.

• Over 30 presentations at national and international scientific meetings
• ESMO Breast Cancer Translational Research Fellowship at Jules Bordet Institute
• Member of European Society of Medical Oncology (ESMO)
• Recipient of multiple awards including ISCORT Best Paper of the Year

Prof. Köstler is a leading expert in personalized cancer medicine, specializing in breast and gynecologic cancers with over two decades of experience.

• Associate Professor at the Medical University of Vienna
• Deputy Head of the Clinical Division of Oncology
• Pioneer in targeted therapies and translational research
• Senior consultant at Wiener Privatklinik

Professor of Medical Oncology with 29 years of experience of experience in hormone therapy at Istanbul Florence Nightingale Hospital.

• Specializes in gastrointestinal oncology since 2005
• Fellowship-trained at Istanbul University Oncology Institute
• Member of ESMO, ASCO, and European Neuroendocrine Tumor Society

Dr. Viola Fox leads the certified cancer center at BKZ Solingen, specializing in advanced hormone therapies for tumor diseases.

• Over 14 years of experience of experience in hematology and oncology
• Qualified specialist in genetics with research in molecular biology
• Member of the American Association for Cancer Research
• Develops and implements innovative treatments for haemato-oncological diseases

Dr. Alemdar specializes in hormone therapy with extensive training in medical oncology at Akdeniz University.

• 20 years of experience of experience in internal medicine and oncology
• Trained at Akdeniz University, a leading medical institution
• Works at Medical Park Antalya Hospital Complex